Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06793878 · ClinicalTrials.gov registry record · NA

School-Based Living In Families With Emotions Training

A NA study of Living in Families With Emotions, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06793878: Completed NA study of Living in Families With Emotions, sponsored by Massachusetts General Hospital.

NCT06793878 is a NA study of Living in Families With Emotions that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06793878, a NA study of Living in Families With Emotions, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The overall purpose of this study is to identify adolescents who are at-risk for psychosis, as evidenced by endorsement of mild-to-moderate, sub-syndromal symptoms, and provide them with a potentially preventive intervention aimed at enhancing resilience.

Primary Outcome

This measure includes participant (both adolescent and parent/caregiver) attendance, with more attendance of the intervention indicating better feasibility and acceptability.

Interventions

  • BEHAVIORAL Living in Families With Emotions

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-01-29
Est. Completion 2024-07-20
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT06793878 record still lists

NCT06793878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Living in Families With Emotions appearing as the primary indexed condition, and to 1 intervention - of which Living in Families With Emotions is the first listed.

NCT06793878 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06793878 about?

NCT06793878 is a clinical study titled "School-Based Living In Families With Emotions Training". The overall purpose of this study is to identify adolescents who are at-risk for psychosis, as evidenced by endorsement of mild-to-moderate, sub-syndromal symptoms, and provide them with a potentially preventive intervention aimed at enhancing resilience.

What is the current status of trial NCT06793878?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-01-29. Estimated completion is 2024-07-20.

What conditions does trial NCT06793878 study?

This clinical trial studies the following conditions: Living in Families With Emotions.

What interventions are being tested in trial NCT06793878?

The interventions under investigation include: Living in Families With Emotions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06793878?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06793878 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06793878's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06793878, the US trial registry maintained by the National Library of Medicine. NCT06793878 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.